TG ImmunoPharma

Hefei TG ImmunoPharma Co., Ltd. is a new research and development institution established based on the foundational scientific research achievements of Academician Zhigang Tian's team from the University of Science and Technology of China. Academician Zhigang Tian's team is one of the leading teams in the global NK cell research field, with over 30 years of experience in NK cell research and more than 20 years of exploring the pharmaceutical value of NK cell receptors. Hefei TG ImmunoPharma Co., Ltd. possesses world-leading R&D technology platforms in areas such as immune checkpoint inhibitors for NK cells, bi/multi-specific antibodies, and immunomodulators. Building on a solid foundation, the TGI team has integrated industry resources to promote the transformation of world-class NK cell immunotherapy research results. It aims to create an immunopharmaceutical development and research base in Hefei Economic and Technological Development Zone, implement industrial projects, and contribute to the pharmaceutical industry cluster.